News | Mammography | June 13, 2018

Women More Likely to Use Other Preventive Health Services Following Mammography

Study finds that even a false-positive mammogram does not deter Medicare patients from seeking out other preventive health measures

Women More Likely to Use Other Preventive Health Services Following Mammography

June 13, 2018 – Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to undergo other preventive health services like screening for cervical cancer and osteoporosis, according to a major new study appearing online in the journal Radiology. Researchers found that even false-positive mammography findings did not reduce the likelihood of women utilizing these other preventive services.

Mammography is among the most commonly offered preventive services for women ages 40 years and older, making it a potentially significant influencer of adherence to other preventive services guidelines. However, little is known about the association between screening mammography and use of a variety of preventive services in the Medicare population, along with the impact of false-positive mammographic findings on preventive services use.

For the new study, researchers from NYU School of Medicine in New York, Emory University in Atlanta and the Harvey L. Neiman Health Policy Institute in Reston, Va., set out to learn more about these associations.

“There were two overarching ideas to this study,” said Stella Kang, M.D., M.Sc., assistant professor of radiology and population health at NYU School of Medicine. “First, we wanted to examine the potential for a patient’s experience with one screening to influence appointments with other preventive services. Second, we wanted to see how the potential harms from false-positive findings might influence preventive service use.”

Kang and colleagues compared preventive services utilization among 185,625 women who underwent mammography from 2010 to 2014 with that of a control group who did not have screening mammography. They zeroed in on the relationship between screening status and the probabilities of undergoing Pap smear, bone mass measurement or influenza vaccination in the two years after mammography. The researchers also looked for a possible association between false-positive mammography results and subsequent use of the same non-mammographic preventive services. In theory, false positives, which require additional examinations and create added stress for the patient, might create negative associations with preventives services.

The results showed that women who underwent mammography screening, with either positive or negative results, were significantly more likely than unscreened women to later utilize the other indicated preventive health services. In women who had not undergone these preventive measures in the two years prior to screening mammography, utilization of all three services after false-positive mammography screening was no different than after a true-negative screening.

“It’s encouraging that women for whom services are received through Medicare are not showing significant signs of any negative influence from mammography,” Kang said. “If anything, the experience of breast cancer screening is potentially encouraging, as it appears to increase awareness of other preventive services.”

There are a number of possible reasons for the increased odds of preventive services utilization, the researchers said. Adherence to screening mammography guidelines suggests a patient may be more proactive about her health in general. Referring physicians may consider a patient’s willingness to undergo mammography as indicative of an understanding or acceptance of the favorable benefit-risk profile of recommended preventive services.

“Our theory is that when patients are counseled about mammography screening, this represents an opportunity for the physician to bring up other preventive services and the health benefits of these services for women in their age group,” Kang said. “So a patient’s interest in breast cancer services specifically could raise awareness in preventive services overall.”

In the future, the researchers plan to look at mammography’s effects on the utilization of other recommended preventive services, such as colorectal cancer screening.

For more information: www.pubs.rsna.org/journal/radiology

Reference

Kang S.K., Jiang M., Duszak R., et al. “Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries.” Radiology, June 5, 2018. https://doi.org/10.1148/radiol.2018172326

Related Content

Christopher Comstock, M.D., ECOG-ACRIN Cancer Research Group study published in JAMA builds evidence for use of abbreviated MRI in women with dense breasts

Christopher Comstock, M.D., (Memorial Sloan Kettering Cancer Center) is the lead author of a paper in JAMA that reports that abbreviated breast MRI detected significantly more (almost 2 and a half times as many) breast cancers than digital breast tomosynthesis (3-D mammography) in average-risk women with dense breasts. Photo courtesy of Memorial Sloan Kettering Cancer Center

News | Breast Imaging | February 26, 2020
February 26, 2020 — According to a study
Women 75-plus May Not Benefit from Breast Cancer Screening
News | Mammography | February 25, 2020
February 25, 2020 — According to newly published research in an article titled...
An example of the MRI scans showing long-term and short-term survival indications. #MRI

An example of the MRI scans showing long-term and short-term survival indications. Image courtesy of Case Western Reserve University

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — ...
A cutting-edge magnet resonance imaging (MRI) technique to detect iron deposits in different brain regions can track declines in thinking, memory and movement in people with Parkinson's disease #Parkinsons #MRI

Summary steps of the processing pipeline for QSM reconstruction (phase pre-processing and map estimation) and whole brain/regional analysis. ANTs, advanced normalisation tools; MP-RAGE, magnetisation-prepared, 3D, rapid, gradient-echo; MSDI, multi-scale dipole inversion; QSM, quantitative susceptibility mapping; ROI, region of interest; SWI, susceptibility weighted imaging.

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — A cutting-edge...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.